Repare Therapeutics Inc. Operating Expenses
Repare Therapeutics Inc. reported Operating Expenses of $13.88 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2025-11-14
- Repare Therapeutics Inc. operating expenses for the quarter ending 2025-09-30 was $13.88M, a 61.85% decline year-over-year.
- Repare Therapeutics Inc. operating expenses for the quarter ending 2025-06-30 was $23.70M, a 38.28% decline year-over-year.
- Repare Therapeutics Inc. operating expenses for the quarter ending 2025-03-31 was $31.19M, a 25.01% decline year-over-year.
- Repare Therapeutics Inc. operating expenses for the quarter ending 2024-12-31 was $30.65M, a 30.21% decline year-over-year.
- Repare Therapeutics Inc. operating expenses for fiscal 2024 was $147.00M, a 12.16% decline from fiscal 2023.
- Repare Therapeutics Inc. operating expenses for fiscal 2023 was $167.36M, a 10.37% increase from fiscal 2022.
- Repare Therapeutics Inc. operating expenses for fiscal 2022 was $151.63M, a 30.42% increase from fiscal 2021.
- Repare Therapeutics Inc. operating expenses for fiscal 2021 was $116.26M, a 113.57% increase from fiscal 2020.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2025-09-30 | $13.88M 10-Q · filed 2025-11-14 | $37.57M derived: sum of 2 quarters · filed 2025-11-14 | $68.76M 10-Q · filed 2025-11-14 | $99.41M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $23.70M 10-Q · filed 2025-08-08 | $54.88M 10-Q · filed 2025-08-08 | $85.53M derived: sum of 3 quarters · filed 2025-08-08 | $121.90M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | $31.19M 10-Q · filed 2025-05-13 | $61.84M derived: sum of 2 quarters · filed 2025-05-13 | $98.21M derived: sum of 3 quarters · filed 2025-11-14 | $136.60M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | $30.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $67.02M derived: sum of 2 quarters · filed 2025-11-14 | $105.41M derived: sum of 3 quarters · filed 2025-11-14 | $147.00M 10-K · filed 2025-03-03 |
| 2024-09-30 | $36.37M 10-Q · filed 2025-11-14 | $74.76M derived: sum of 2 quarters · filed 2025-11-14 | $116.35M 10-Q · filed 2025-11-14 | $160.27M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $38.39M 10-Q · filed 2025-08-08 | $79.98M 10-Q · filed 2025-08-08 | $123.89M derived: sum of 3 quarters · filed 2025-08-08 | $164.47M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $41.59M 10-Q · filed 2025-05-13 | $85.50M derived: sum of 2 quarters · filed 2025-05-13 | $126.08M derived: sum of 3 quarters · filed 2025-05-13 | $168.59M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $43.91M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $84.49M derived: sum of 2 quarters · filed 2025-03-03 | $127.00M derived: sum of 3 quarters · filed 2025-03-03 | $167.36M 10-K · filed 2025-03-03 |
| 2023-09-30 | $40.58M 10-Q · filed 2024-11-07 | $83.08M derived: sum of 2 quarters · filed 2024-11-07 | $123.44M 10-Q · filed 2024-11-07 | $161.27M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $42.51M 10-Q · filed 2024-08-06 | $82.87M 10-Q · filed 2024-08-06 | $120.70M derived: sum of 3 quarters · filed 2024-08-06 | $159.84M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $40.36M 10-Q · filed 2024-05-07 | $78.19M derived: sum of 2 quarters · filed 2024-05-07 | $117.33M derived: sum of 3 quarters · filed 2024-05-07 | $156.75M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $37.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $76.98M derived: sum of 2 quarters · filed 2024-02-28 | $116.39M derived: sum of 3 quarters · filed 2024-02-28 | $151.63M 10-K · filed 2024-02-28 |
| 2022-09-30 | $39.15M 10-Q · filed 2023-11-09 | $78.56M derived: sum of 2 quarters · filed 2023-11-09 | $113.80M 10-Q · filed 2023-11-09 | $149.41M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $39.41M 10-Q · filed 2023-08-09 | $74.65M 10-Q · filed 2023-08-09 | $110.26M derived: sum of 3 quarters · filed 2023-08-09 | $142.22M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $35.24M 10-Q · filed 2023-05-09 | $70.85M derived: sum of 2 quarters · filed 2023-05-09 | $102.81M derived: sum of 3 quarters · filed 2023-05-09 | $129.75M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $35.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $67.57M derived: sum of 2 quarters · filed 2023-02-28 | $94.51M derived: sum of 3 quarters · filed 2023-02-28 | $116.26M 10-K · filed 2023-02-28 |
| 2021-09-30 | $31.96M 10-Q · filed 2022-11-09 | $58.90M derived: sum of 2 quarters · filed 2022-11-09 | $80.65M 10-Q · filed 2022-11-09 | $97.86M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $26.95M 10-Q · filed 2022-08-04 | $48.69M 10-Q · filed 2022-08-04 | $65.90M derived: sum of 3 quarters · filed 2022-08-04 | $79.99M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $21.75M 10-Q · filed 2022-05-05 | $38.96M derived: sum of 2 quarters · filed 2022-05-05 | $53.05M derived: sum of 3 quarters · filed 2022-05-05 | $65.37M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $17.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $31.30M derived: sum of 2 quarters · filed 2022-03-01 | $43.62M derived: sum of 3 quarters · filed 2022-03-01 | $54.44M 10-K · filed 2022-03-01 |
| 2020-09-30 | $14.09M 10-Q · filed 2021-11-10 | $26.41M derived: sum of 2 quarters · filed 2021-11-10 | $37.23M 10-Q · filed 2021-11-10 | $46.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $12.32M 10-Q · filed 2021-08-12 | $23.14M 10-Q · filed 2021-08-12 | $31.98M derived: sum of 3 quarters · filed 2022-03-01 | $38.85M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $10.81M 10-Q · filed 2021-05-13 | $19.66M derived: sum of 2 quarters · filed 2022-03-01 | $26.53M derived: sum of 3 quarters · filed 2022-03-01 | $32.41M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $15.71M derived: sum of 2 quarters · filed 2022-03-01 | $21.60M derived: sum of 3 quarters · filed 2022-03-01 | $26.38M 10-K · filed 2022-03-01 |
| 2019-09-30 | $6.87M 10-Q · filed 2020-11-12 | $12.75M derived: sum of 2 quarters · filed 2020-11-12 | $17.53M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $5.88M 10-Q · filed 2020-08-13 | $10.66M 10-Q · filed 2020-08-13 |